vs
Side-by-side financial comparison of Cheche Group Inc. (CCG) and IRONWOOD PHARMACEUTICALS INC (IRWD). Click either name above to swap in a different company.
IRONWOOD PHARMACEUTICALS INC is the larger business by last-quarter revenue ($47.7M vs $32.8M, roughly 1.5× Cheche Group Inc.). Cheche Group Inc. runs the higher net margin — 0.5% vs -4.8%, a 5.2% gap on every dollar of revenue.
Cheche Group Inc. is a leading automotive digital service provider headquartered in China. It offers integrated solutions including auto insurance intermediary services, smart auto after-sales support, and connected vehicle technology products, serving individual car owners, auto dealerships, and insurance partners across domestic and select Southeast Asian markets.
Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.
CCG vs IRWD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $32.8M | $47.7M |
| Net Profit | $153.6K | $-2.3M |
| Gross Margin | 5.7% | — |
| Operating Margin | — | 14.3% |
| Net Margin | 0.5% | -4.8% |
| Revenue YoY | — | -47.3% |
| Net Profit YoY | — | -200.9% |
| EPS (diluted) | $0.00 | $0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $32.8M | — | ||
| Q4 25 | — | $47.7M | ||
| Q3 25 | — | $122.1M | ||
| Q2 25 | $26.0M | $85.2M | ||
| Q1 25 | — | $41.1M | ||
| Q4 24 | $18.6M | $90.5M | ||
| Q3 24 | — | $91.6M | ||
| Q2 24 | $36.1M | $94.4M |
| Q1 26 | $153.6K | — | ||
| Q4 25 | — | $-2.3M | ||
| Q3 25 | — | $40.1M | ||
| Q2 25 | $-492.4K | $23.6M | ||
| Q1 25 | — | $-37.4M | ||
| Q4 24 | $-196.7K | $2.3M | ||
| Q3 24 | — | $3.6M | ||
| Q2 24 | $-7.6M | $-860.0K |
| Q1 26 | 5.7% | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 4.9% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 5.2% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 4.3% | — |
| Q1 26 | — | — | ||
| Q4 25 | — | 14.3% | ||
| Q3 25 | — | 61.8% | ||
| Q2 25 | -2.0% | 53.2% | ||
| Q1 25 | — | -70.7% | ||
| Q4 24 | -0.3% | 34.8% | ||
| Q3 24 | — | 28.0% | ||
| Q2 24 | -4.7% | 26.5% |
| Q1 26 | 0.5% | — | ||
| Q4 25 | — | -4.8% | ||
| Q3 25 | — | 32.8% | ||
| Q2 25 | -1.9% | 27.7% | ||
| Q1 25 | — | -90.9% | ||
| Q4 24 | -1.1% | 2.5% | ||
| Q3 24 | — | 4.0% | ||
| Q2 24 | -21.0% | -0.9% |
| Q1 26 | $0.00 | — | ||
| Q4 25 | — | $0.01 | ||
| Q3 25 | — | $0.23 | ||
| Q2 25 | $-0.01 | $0.14 | ||
| Q1 25 | — | $-0.23 | ||
| Q4 24 | $-0.00 | $0.03 | ||
| Q3 24 | — | $0.02 | ||
| Q2 24 | — | $-0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $20.0M | $215.5M |
| Total DebtLower is stronger | $193.3K | — |
| Stockholders' EquityBook value | — | $-261.8M |
| Total Assets | $203.5M | $396.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $20.0M | — | ||
| Q4 25 | — | $215.5M | ||
| Q3 25 | — | $140.4M | ||
| Q2 25 | $23.1M | $92.9M | ||
| Q1 25 | — | $108.5M | ||
| Q4 24 | $21.1M | $88.6M | ||
| Q3 24 | — | $88.2M | ||
| Q2 24 | $28.2M | $105.5M |
| Q1 26 | $193.3K | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | $199.5M | ||
| Q2 25 | $690.0K | $199.3M | ||
| Q1 25 | — | $199.2M | ||
| Q4 24 | — | $199.0M | ||
| Q3 24 | — | $198.8M | ||
| Q2 24 | — | $198.6M |
| Q1 26 | — | — | ||
| Q4 25 | — | $-261.8M | ||
| Q3 25 | — | $-264.2M | ||
| Q2 25 | $47.1M | $-308.2M | ||
| Q1 25 | — | $-334.1M | ||
| Q4 24 | $49.1M | $-301.3M | ||
| Q3 24 | — | $-311.3M | ||
| Q2 24 | $48.6M | $-321.7M |
| Q1 26 | $203.5M | — | ||
| Q4 25 | — | $396.9M | ||
| Q3 25 | — | $396.1M | ||
| Q2 25 | $177.3M | $342.9M | ||
| Q1 25 | — | $327.2M | ||
| Q4 24 | $177.7M | $350.9M | ||
| Q3 24 | — | $389.5M | ||
| Q2 24 | $139.3M | $395.6M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.01× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $74.6M |
| Free Cash FlowOCF − Capex | — | $74.6M |
| FCF MarginFCF / Revenue | — | 156.3% |
| Capex IntensityCapex / Revenue | — | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $127.0M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | $74.6M | ||
| Q3 25 | — | $47.6M | ||
| Q2 25 | $-44.7M | $-15.1M | ||
| Q1 25 | — | $20.0M | ||
| Q4 24 | $-15.8M | $15.2M | ||
| Q3 24 | — | $9.9M | ||
| Q2 24 | $-1.0K | $33.5M |
| Q1 26 | — | — | ||
| Q4 25 | — | $74.6M | ||
| Q3 25 | — | $47.6M | ||
| Q2 25 | — | $-15.1M | ||
| Q1 25 | — | $19.9M | ||
| Q4 24 | $-16.0M | — | ||
| Q3 24 | — | $9.9M | ||
| Q2 24 | $-1.1K | $33.4M |
| Q1 26 | — | — | ||
| Q4 25 | — | 156.3% | ||
| Q3 25 | — | 39.0% | ||
| Q2 25 | — | -17.7% | ||
| Q1 25 | — | 48.4% | ||
| Q4 24 | -85.9% | — | ||
| Q3 24 | — | 10.8% | ||
| Q2 24 | -0.0% | 35.4% |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | 1.2% | 0.0% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | 0.0% | 0.1% |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 1.19× | ||
| Q2 25 | — | -0.64× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 6.74× | ||
| Q3 24 | — | 2.71× | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
